Viral Hepatitis

Top Story

In HBV, high core-related antigen levels predict cirrhosis

September 19, 2017

Elevated hepatitis B virus core-related antigen levels significantly increased the risk for progression to cirrhosis among patients with chronic hepatitis B who are hepatitis B e antigen-negative and are not receiving nucleos(t)ide analogue therapy, according to recently published data.

“Recently, various indices of liver fibrosis based on clinical and biological data have been reported to be useful predictors of fibrosis in liver disease,” Toshifumi Tada, MD, from the Ogaki Municipal Hospital, Japan, and colleagues wrote. “Our findings suggest that an elevated HBcrAg level should be considered a new criterion for starting antiviral therapy in order to decrease the risk of cirrhosis in HBV carriers.”

In the Journals

Reused medical needles lead to most HCV infections in India

September 19, 2017
“As there exists a regional variation in the prevalence of HCV and health care practices, studying the clinical profile of HCV in different parts of the world…
Meeting News

Transmission, reinfection common in prisoners with HCV who inject drugs

September 15, 2017
Hepatitis C transmission rates were high in Australian prisons and significantly correlated with injection drug use, according to a presentation at the International…
In the Journals

Low-income nations need greater health investments to eliminate HBV

September 15, 2017
Higher-income northern and western European countries ranked the highest on the United Nation’s health-related Sustainable Development Goals index in 2016…
More Headlines »
CME

HCV Updates and Case Challenges for the Rapidly Changing Landscape

This activity is supported by an educational grant from Merck & Co., Inc.

In the past few years, significant progress has been made in the treatment of chronic hepatitis C virus (HCV). Highly…
More »
GI Bookshelf

Chapter 5: Dysplasia And Colorectal Cancer

From Clinical Challenges and Complications of IBD
More »
Resource Centers
International Liver Congress

International Liver Congress

Video
Meeting News Coverage

New treatments transform HCV management

October 3, 2013
More »
Advertisement
Advertisement